Autoantibodies to β2m have also been found in AS patients, at frequencies similar to those in patients with SLE (68% and 71%, respectively), which are much higher than those in RA patients (27%) and healthy controls (5%) [74]. Here, B2M is linked to rheumatoid arthritis.